Autolus Therapeutics (AUTL) Earnings Date & Reports

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUTL is expected to report earnings to fall 11.81% to -22 cents per share on July 31

Autolus Therapeutics AUTL Stock Earnings Reports

Q2'25

Est.

$-0.23

Q1'25

Est.

$-0.26

Q4'24

Beat

by $0.12

Q3'24

Missed

by $0.10

Q2'24

Missed

by $0.03

The last earnings report on May 08 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 71.49K shares outstanding, the current market capitalization sits at 588.16M.

View a ticker or compare two or three

Compare

AUTL